FTT.AX - Factor Therapeutics Limited

ASX - ASX Delayed price. Currency in AUD
Currency in AUD

Valuation measures

Market cap (intra-day) 53.13M
Enterprise value 389.7k
Trailing P/E 1.50
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)1.26
Price/book (mrq)1.00
Enterprise value/revenue 30.04
Enterprise value/EBITDA 60.05

Trading information

Stock price history

Beta (5Y monthly) 1.27
52-week change 3-40.00%
S&P500 52-week change 38.60%
52-week high 30.0050
52-week low 30.0010
50-day moving average 30.0028
200-day moving average 30.0028

Share statistics

Avg vol (3-month) 34.06M
Avg vol (10-day) 36.44M
Shares outstanding 51.04B
Float 432.88M
% held by insiders 146.47%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:1
Last split date 304 Feb 2009

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2019
Most-recent quarter (mrq)31 Dec 2019

Profitability

Profit margin 67.04%
Operating margin (ttm)66.35%

Management effectiveness

Return on assets (ttm)34.92%
Return on equity (ttm)90.15%

Income statement

Revenue (ttm)2.49M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)2.41M
EBITDA 1.65M
Net income avi to common (ttm)1.67M
Diluted EPS (ttm)0.0020
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.04M
Total cash per share (mrq)0
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)12.78
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)26.28k
Levered free cash flow (ttm)-601.91k